{"data":{"id":"us/21-cfr-601.93","jurisdiction":"us","citation":"21 CFR 601.93","heading":"Postmarketing safety reporting.","body":"Biological products approved under this subpart are subject to the postmarketing recordkeeping and safety reporting applicable to all approved biological products.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER F—BIOLOGICS","PART 601—LICENSING","Subpart H—Approval of Biological Products When Human Efficacy Studies Are Not Ethical or Feasible"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"abf08bc7598323f779f8aa1515386fe8cb64bb682893d7e798c917e037710a3a","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-601.92","next":"us/21-cfr-601.94"},"notice":"GroundRules: Original legal text. Not legal advice."}